Holdings (43)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 9.41709433% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 7.0421288% |
| Lupin Ltd. | Healthcare | Equity | 5.78670597% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 4.24748723% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 3.74569399% |
| Gland Pharma Ltd. | Healthcare | Equity | 3.54410565% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 3.51707962% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 3.48055698% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 3.46509675% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 2.98115822% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 7.37% | 26.73% | 17.10% | 14.85% |
| Category Average | -2.14% | 22.11% | 14.61% | NA% |
| Rank Within Category | 11.00% | 3.00% | 5.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 1.3%
Inclusive of GST
Exit load
Exit load of 1% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Mr. Gada is B.com, CA, CS, & CFA
Experience
Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.